The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 488.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.459%)
Open: 494.00
High: 494.00
Low: 494.00
Prev. Close: 494.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment – SAGE Program Underwriters

29 Jun 2020 07:00

RNS Number : 2940R
B.P. Marsh & Partners PLC
29 June 2020
 

29 June 2020

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

Investment - SAGE Program Underwriters

 

B.P. Marsh and Partners Plc (AIM:BPM), the specialist private equity investor in early stage financial services businesses is pleased to announce that it has agreed to subscribe for a 30% Cumulative Preferred Ordinary shareholding in SAGE Program Underwriters ("SAGE"), for an equity consideration of $250,000 (c. £200,000).

 

Based in Bend, Oregon, USA, and established in 2019, by CEO Chuck Holdren, SAGE provides specialist insurance products to niche industries, initially in the inland delivery and field sport sectors. 

 

Mr Holdren has over 3 decades of experience in the insurance industry. Prior to establishing SAGE, he founded and managed two national underwriting agencies from start-up to successful trade sale. He has also worked in senior management roles across the insurance sector. 

 

During his career, Mr Holdren has designed and implemented numerous underwriting programs for niche insurance sectors and has many long-lasting relationships with agents, brokers, and insurers across the USA. 

 

Before making this investment, the Company assessed the potential impact of the Covid-19 pandemic on SAGE. Given SAGE's focus on the Inland Delivery sector, a business segment that has continued to operate during the wider Covid-19 close down, the Company believes that SAGE is well positioned to trade through Covid-19. 

 

In addition to the equity consideration, the Company will provide a loan facility to SAGE of $250,000 (c. £200,000). This facility is available from completion and will be utilised by SAGE to bring about future growth, as outlined in the agreed business plan. 

 

Dan Topping, Chief Investment Officer of the Company, commenting on this investment, stated "We are pleased to be investing in SAGE, and we look forward to developing a successful partnership with Chuck and his team. He has a fine reputation for providing solutions to particular sectors which were previously underserved in the Workers Compensation insurance market. 

 

The specialist nature of SAGE within the insurance sector corresponds with our investment approach in seeking partnerships with skilled management teams." 

 

Chuck Holdren, SAGE's CEO, commented "We are thrilled to have B.P. Marsh as a partner in SAGE to help support our current and long-term goals. In addition to the financial investment, the team at B.P. Marsh brings a significant amount of insurance experience, expertise, and relationships. This allows SAGE to develop new programs, coverages and talent that we have already identified that will position us to be the leading insurance provider for the industries we serve." 

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEAPKPAANEEFA
Date   Source Headline
19th Apr 20233:55 pmRNSTransaction in Own Shares
18th Apr 20236:04 pmRNSAward of Shares under Share Incentive Plan
17th Apr 20234:58 pmRNSTransaction in Own Shares
13th Apr 20233:28 pmRNSTransaction in Own Shares
12th Apr 20232:17 pmRNSTransaction in Own Shares
6th Apr 20233:56 pmRNSTransaction in Own Shares
5th Apr 20235:14 pmRNSTransaction in Own Shares
5th Apr 20234:12 pmRNSTransfer of Treasury Shares
4th Apr 20234:30 pmRNSTransaction in Own Shares
30th Mar 202310:30 amRNSTransaction in Own Shares
21st Mar 20232:14 pmRNSTransaction in Own Shares
20th Mar 20232:07 pmRNSTransaction in Own Shares
14th Mar 20234:00 pmRNSTransaction in Own Shares
14th Mar 20233:40 pmRNSTransaction in Own Shares
10th Mar 20232:19 pmRNSTransaction in Own Shares
7th Mar 20239:22 amRNSTransaction in Own Shares
3rd Mar 20239:58 amRNSTransaction in Own Shares
2nd Mar 20239:22 amRNSTransaction in Own Shares
1st Mar 20239:10 amRNSTransaction in Own Shares
27th Feb 20231:08 pmRNSTransaction in Own Shares
22nd Feb 20235:21 pmRNSTransaction in Own Shares
21st Feb 20234:31 pmRNSTransaction in Own Shares
21st Feb 20239:13 amRNSTransaction in Own Shares
16th Feb 20233:56 pmRNSTransaction in Own Shares
16th Feb 20238:52 amRNSTransaction in Own Shares
14th Feb 20234:40 pmRNSTransaction in Own Shares
14th Feb 20234:39 pmRNSTransaction in Own Shares
14th Feb 20237:00 amRNSTrading Update
9th Feb 202310:58 amRNSTransaction in Own Shares
6th Feb 20234:15 pmRNSInvestee Company Update - XPT Group LLC
3rd Feb 20239:22 amRNSTransaction in Own Shares
27th Jan 20232:17 pmRNSTransaction in Own Shares
25th Jan 20235:04 pmRNSTransaction in Own Shares
20th Jan 202310:39 amRNSTransaction in Own Shares
18th Jan 20235:22 pmRNSTransaction in Own Shares
16th Jan 20237:00 amRNSInterim Dividend Declaration and Share Buy-Back
9th Jan 202312:00 pmRNSInvestee Company Updates
6th Jan 20234:43 pmRNSHolding(s) in Company
22nd Dec 20222:57 pmRNSDirector/PDMR Shareholding
29th Nov 20224:15 pmRNSDirector/PDMR Shareholding
18th Nov 202210:32 amRNSDirector/PDMR Shareholding
2nd Nov 202212:30 pmRNSInvestee Company - Update Denison and Partners
19th Oct 202212:11 pmRNSDirector/PDMR Shareholding
18th Oct 20227:00 amRNSInterim Results
6th Oct 202210:02 amRNSNotice of Interim Results & Investor Presentation
20th Sep 202211:25 amRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSTrading Update
15th Aug 20224:39 pmRNSDirector/PDMR Shareholding
25th Jul 20223:31 pmRNSResult of AGM
15th Jul 20221:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.